Adverse Effects of IL-12
| Event . | Number . |
|---|---|
| Myalgias | 5 |
| Chills | 4 |
| Fatigue* | 2 |
| Loose stools | 2 |
| Elevated liver enzymes† | 2 |
| Loss of appetite | 2 |
| Headache | 2 |
| Depression‡ | 1 |
| Leukopenia | 1 |
| Event . | Number . |
|---|---|
| Myalgias | 5 |
| Chills | 4 |
| Fatigue* | 2 |
| Loose stools | 2 |
| Elevated liver enzymes† | 2 |
| Loss of appetite | 2 |
| Headache | 2 |
| Depression‡ | 1 |
| Leukopenia | 1 |
Fatigue occurred in one patient entered at 300 ng/kg and in one patient dose-escalated to 300 ng/kg necessitating dose decrease in both cases.
Elevated liver enzymes occurred in the context of alcohol ingestion at a dose of 300 ng/kg and rapidly returned to baseline values with the holding of a single dose of rhIL-12.
Depression occurred at a dose of 100 ng/kg necessitating discontinuation of rhIL-12. This patient had experienced severe depression during the previous administration of recombinant IFN-α.